Literature DB >> 8591699

Respiratory burst activity of monocytes from patients with non-insulin-dependent diabetes mellitus.

F Y Chang1, M F Shaio.   

Abstract

Monocytes from patients with poorly controlled non-insulin-dependent diabetes mellitus (NIDDM) show a decrease in intracellular bactericidal function. To determine whether this reduced bactericidal function is mediated by an impaired oxygen-dependent mechanism, we assayed the production of superoxide (O2-) and hydrogen peroxide (H2O2) by monocytes from poorly controlled NIDDM patients (n = 12), well controlled NIDDM patients (n = 12) and healthy subjects (n = 16). Using phorbol myristate acetate (PMA) as stimulant, the production of O2- by fresh monocytes was significantly decreased in poorly controlled NIDDM patients (231 +/- 30 nmol/mg protein/2-h) as compared with that of well controlled NIDDM patients (430 +/- 81 nmol/mg protein/2-h) and that of healthy subjects (399 +/- 61 nmol/mg protein/2-h), respectively (P < 0.05). Using opsonized zymosan (OZ) as stimulant, the production of O2- by fresh monocytes was also notably decreased in patients with poorly controlled NIDDM (312 +/- 42 nmol/mg protein/2-h) as compared with that of patients with well controlled NIDDM (688 +/- 92 nmol/mg protein/2-h) and that of healthy subjects (539 +/- 96 nmol/mg protein/2-h), respectively (P < 0.05). Poorly controlled NIDDM patients had a significant decrease in the production of H2O2 by monocytes, either stimulated by PMA or OZ, as compared with that of well controlled NIDDM patients and that of healthy subjects, respectively (P < 0.05). Enhancement of the production of O2- and H2O2 occurred in healthy subjects (150% increase) as well as NIDDM patients (170% increase) after a preincubation of monocytes with interferon-gamma (IFN-gamma 100 U/ml) for 48 h. The respiratory burst activity of both fresh and cultured monocytes from well controlled NIDDM patients was not significantly different from that of healthy subjects. This study suggests that both, strict metabolic control and in vitro culture with IFN-gamma may improve the monocyte oxygen-dependent bactericidal mechanism in NIDDM patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591699     DOI: 10.1016/0168-8227(95)01123-4

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  11 in total

1.  Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice.

Authors:  Hideaki Yamasawa; Masayuki Nakayama; Masashi Bando; Yukihiko Sugiyama
Journal:  Inflamm Res       Date:  2012-01-07       Impact factor: 4.575

2.  Correction of aberrant NADPH oxidase activity in blood-derived mononuclear cells from type II diabetes mellitus patients by a naturally fermented papaya preparation.

Authors:  Ryan Dickerson; Bhakthi Deshpande; Urmila Gnyawali; Debbie Lynch; Gayle M Gordillo; Dara Schuster; Kwame Osei; Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2012-04-26       Impact factor: 8.401

3.  Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes.

Authors:  Yong Ding; Alpdogan Kantarci; Hatice Hasturk; Philip C Trackman; Alan Malabanan; Thomas E Van Dyke
Journal:  J Leukoc Biol       Date:  2006-11-09       Impact factor: 4.962

4.  Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus.

Authors:  Sunny Park; Jeremy Rich; Frank Hanses; Jean C Lee
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

Review 5.  Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research.

Authors:  Helen McIlleron; Susan Abdel-Rahman; Joel Alex Dave; Marc Blockman; Andrew Owen
Journal:  J Infect Dis       Date:  2015-06-15       Impact factor: 5.226

6.  The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.

Authors:  Matthias Oelze; Swenja Kröller-Schön; Philipp Welschof; Thomas Jansen; Michael Hausding; Yuliya Mikhed; Paul Stamm; Michael Mader; Elena Zinßius; Saule Agdauletova; Anna Gottschlich; Sebastian Steven; Eberhard Schulz; Serge P Bottari; Eric Mayoux; Thomas Münzel; Andreas Daiber
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 7.  Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective.

Authors:  Junghyun Noh; Hyun Ha Chang; In Kyung Jeong; Kun Ho Yoon
Journal:  Diabetes Metab J       Date:  2020-06       Impact factor: 5.376

8.  Altered polarization, morphology, and impaired innate immunity germane to resident peritoneal macrophages in mice with long-term type 2 diabetes.

Authors:  Hui-Fang Liu; Hui-Jie Zhang; Qi-Xian Hu; Xiao-Yan Liu; Zhi-Quan Wang; Jia-Yan Fan; Ming Zhan; Feng-Ling Chen
Journal:  J Biomed Biotechnol       Date:  2012-10-03

9.  Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity.

Authors:  María Teresa Herrera; Yolanda Gonzalez; Fernando Hernández-Sánchez; Guadalupe Fabián-San Miguel; Martha Torres
Journal:  BMC Infect Dis       Date:  2017-09-07       Impact factor: 3.090

10.  Analysis of prognostic factors affecting poor outcomes in 41 cases of Fournier gangrene.

Authors:  Hyung Min Hahn; Kwang Sik Jeong; Dong Ha Park; Myong Chul Park; Il Jae Lee
Journal:  Ann Surg Treat Res       Date:  2018-11-26       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.